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Coronary artery dilatations are characterized by an enlarged
coronary artery lumen more than 1.5 times the diameter of
normal adjacent segments or the diameter of the patient’s lar-
gest coronary artery. They are divided into coronary artery
ectasia and aneurysms. Coronary ectasias are diffuse and
involve 50% or more of the length of the artery, while coronary
artery aneurysms (CAAs) are more focal, involving <50% of the
total length of the vessel. In children, according to the AHA
classiﬁcation a diagnosis of a CAA is based on a coronary artery
Z score ≥2.5. CAAs are characterized as giant when the max-
imal diameter exceeds 20mm in adults and 8mm or a coronary
artery Z score ≥10 in children [1, 2]. The biggest CAA described
had a maximum diameter of 180mm [3].
Aneurysmal coronary artery disease is a relatively uncom-
mon entity found in 0.3–5% of adult patients undergoing inva-
sive coronary angiograms. Giant CAAs are very rare, with an
estimated prevalence of 0.02–0.2% [4], however, they have been
reported in 5.9% of patients with congenital coronary artery ﬁs-
tulas [5]. The underlying aetiology for CAAs varies geographic-
ally and with age; atherosclerosis accounts for around half of
the cases identiﬁed in the Western world, while Kawasaki dis-
ease is more common worldwide with development of CAAs in
12–25% of untreated patients. Other causes include connective
tissue disease, congenital disease, vasculitis/inﬂammation and
trauma/iatrogenic [6, 7]. Giant CAAs may present with angina,
especially when they are related to atherosclerotic cardiovascu-
lar disease, or may be an incidental ﬁnding in asymptomatic
patients. Because of the rarity of giant CAAs, the exact natural
progression is unknown, and treatment is not well established.
Surgery is usually performed in patients with obstructive coron-
ary artery disease, angina, arrhythmias or other complications,
while asymptomatic patients especially those with untreated
Kawasaki disease can be offered antiplatelet or antithrombotic
treatment [4, 8, 9].
The case report by Ab Hamid and Joshi [10] published in the
Oxford Medical Case Reports, describes the very rare presenta-
tion of an asymptomatic 71-year-old patient with giant CAAs in
all three coronary arteries. Cardiomegaly on chest X-ray for
pneumonia prompted further investigation with echocardiog-
raphy and then cardiovascular magnetic resonance (CMR)
imaging and computed tomography coronary angiogram (CTCA).
Interestingly, despite their size and the presence of circumferen-
tial intramural thrombus the giant CAAs caused no obstruction
to adjacent cardiac chambers, no evidence of cardiac ischaemia
on stress echocardiography and there was no myocardial infarc-
tion on CMR late gadolinium imaging. The authors concluded
that the giant CAAs in their patient could reﬂect either
undiagnosed childhood Kawasaki disease or they might be
congenital due to coexisting multiple dilated venous struc-
tures in the chest. Nevertheless, atherosclerosis is the most
common aetiology of CAAs in the general population, and in
this patient atherosclerosis could well be the explanation as
coronary artery calciﬁcations were evident on the CT coron-
ary angiogram.
This case illustrates the important role of advanced modern
imaging modalities in diagnosing disease entities that were
previously considered rare. CTCA has shown high accuracy for
diagnosing obstructive coronary artery disease [11], and it has
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been proposed in the United Kingdom NICE guidelines [12] as
the non-invasive, cost-effective test of choice, that can act as a
gate keeper for invasive catheterization. This is projected to
result in an increase in the number of cardiac CT scans across
the UK by 700% [12] and as a consequence an increased rate of
recognition of coronary artery dilatations. CTCA can provide
information about the number, the exact location, the size of
the aneurysms, the layers of the vessel wall involved, the pres-
ence of intraluminal thrombi and the associated complications.
CMR has further changed the dynamic of non-invasive imaging
by providing simultaneous assessment of ventricular function,
wall motion, myocardial perfusion, and tissue characterization in
a single examination without potentially harmful ionizing radi-
ation. It has gained an important role in the evaluation and man-
agement of patients with coronary artery disease [13]. Although
CMR coronary angiography remains technically challenging, it can
precisely delineate CAAs in the proximal segments of coronary
arteries and assess for complications such as intraluminal throm-
bosis, myocardial ischaemia or infarction. Furthermore, MR angi-
ography can provide a radiation-free evaluation for aneurysms
in other arterial beds [14]. CMR thus offers a valuable tool
for the initial assessment, risk stratiﬁcation and long-term
surveillance of patients with CAAs, especially in young
patients with previous Kawasaki disease where the cumula-
tive risk of life-time radiation exposure is high [15].
To conclude, the increasing use of advanced non-invasive
modalities to image the coronary arteries and to assess cardiac
function will lead to increased recognition of entities such as cor-
onary artery aneurysms that were previously thought to be
uncommon. As a result, more data on the true burden, the dis-
ease course, treatment options and outcomes are needed to
make therapeutic decisions especially in asymptomatic patients.
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